Objective. This study assesses swallowing function following chemoradiotherapy and neck dissection in head and neck cancer patients and investigates clinical, treatment, and neck dissection factors associated with dysphagia.
T reatment of advanced head and neck cancer (HNC) often involves aggressive chemoradiotherapy (CRT). Multiple studies have demonstrated that intensive CRT regimens are effective in the management of HNC, with improved survival and organ preservation rates. 1, 2 Late toxicities and quality of life have surfaced as important issues for survivors. 3 Dysphagia occurs in 37% to 82% of patients after CRT and has been evaluated in several studies. [4] [5] [6] [7] [8] [9] [10] Dysphagia after CRT limits oral diet and often necessitates a gastrostomy feeding tube (GT) for adequate nutrition. Long-term GT dependence after CRT adversely influences quality of life in HNC patients. 11 The additional impact of neck dissection (ND) after CRT on swallowing function is less well understood. Reports by Machtay et al 12 and Lango et al 13 have suggested increased late toxicity and GT dependence in patients undergoing ND after CRT.
The goals of this retrospective study are to characterize the swallowing ability in HNC patients undergoing ND after CRT at our institution and to evaluate the impact of clinical, treatment, and ND factors on dysphagia measures in these patients.
Methods
All eligible patients who underwent ND after treatment with CRT for an advanced-stage squamous cell carcinoma of the oropharynx, hypopharynx, larynx, or unknown primary at the Brigham and Women's Hospital or Dana-Farber Cancer Institute between January 1998 and June 2008 were reviewed from electronic and paper chart medical records. Patients with cancers of the oral cavity, sinonasal cavity, nasopharynx, or salivary glands were excluded, as were patients with recurrent disease or history of other malignancies. All patients included had a primary site complete response to CRT at the time of ND and a follow-up of at least 24 months after CRT without a recurrence during this time. The protocol was approved by the Dana-Farber Cancer Institute institutional review board.
Neck Dissection
ND was advised for patients who did not achieve a complete response in the neck. In addition, during a portion of this time period, some patients with initial extensive N2b or N3 neck disease underwent ND regardless of response to treatment.
The following ND variables were tabulated: ND timing from completion of CRT, type of ND, and ND complications. ND were either radical neck dissection (RND), modified radical neck dissection (MRND), or selective neck dissection (SND), depending on neck stage, response to CRT, and surgeon preference. ND complications were categorized as "at least 1 wound complication" and "at least 1 complication." The category "at least 1 wound complication" captures all minor wound infections such as fluid collections, wound dehiscence, flap necrosis, and also major wound complications, defined as those requiring hospital readmission, a return to the operating room, or any chyle leak. The second category, "at least 1 complication," summarizes all complications including wound, airway, and systemic complications. Patients undergoing tracheotomy for perioperative airway stabilization were also recorded.
Dysphagia Outcome Measures
Dysphagia assessments included weight loss, diet, GT status, and Diet/GT score. These measures were assessed at 6, 12, and 24 months. Weight loss was compared with pretreatment weight. Diet was reviewed and described with the following 5 categories: nil per os (NPO), liquid, pureed, soft, and regular diet. In this retrospective study, pretreatment diet was not consistently recorded and therefore not available for this analysis. All patients were advised to undergo placement of a GT before the start of concurrent chemoradiotherapy. Length of GT dependency was calculated from completion of CRT. A Diet/GT Scale, with a score ranging from 1 to 5, was newly constructed, combining GT status and diet. The scale is described in Table 1 .
Video swallow studies were performed in patients with significant swallowing difficulties after treatment. The presence of aspiration was graded according to the Penetration-Aspiration Scale (PAS). 14 We considered a PAS of ≥4 to represent significant aspiration. Strictures were also noted, and patients were considered to have significant stenosis if dilation was required.
Statistics
Univariate and multivariate analyses were carried out using logistic regression (GT status and stenosis outcomes) and ordinal logistic regression (Diet/GT score outcome) to assess whether clinical, treatment, and ND variables were associated with the dysphagia outcome measures. Clinical variables used for analysis included age, gender, tumor site, tumor stage (T-stage), and neck stage. Treatment variables considered were type of chemotherapy (induction vs concurrent CRT) and type of radiation therapy. ND variables included type of ND (RND vs MRND/SND), time of ND (<12 weeks vs ≥12 weeks after CRT), ND complications, and need for tracheotomy. The Wald χ 2 test for logistic regression was used to investigate the statistical significance of associations. Variables that could not be analyzed using logistic regression because of small cell numbers were analyzed with the Fisher exact test. Potential predictors identified in univariate analysis were further entered in multiple regression analyses using a P value of <.25 for entry. The final model was chosen by the Akaike Information Criterion. The multivariate analysis also included age and type of chemotherapy. A 2-sided P value <.05 was considered to be significant.
All statistical analyses were performed using SAS for Windows software, version 9.2 (SAS Institute, Cary, North Carolina).
Results

Clinical Variables
One hundred seventeen patients were identified. Nineteen were excluded because of recurrence, and 10 were excluded because of insufficient follow-up (<24 months), resulting in 88 eligible patients for this analysis. The mean follow-up from end of CRT for all patients was 70 months, with a range from 24 to 136 months. Clinical characteristics are listed in Table 2 . All patients had advanced-stage disease, with 87 of 88 having stage IV and 1 of 88 having stage III. Most patients, 82%, had oropharyngeal primaries. GT present and soft/regular diet 4
No GT and liquid/pureed diet 5
No GT and soft/regular diet Abbreviations: GT, gastrostomy tube; NPO, nil per os.
Treatment Variables
Treatment characteristics are listed in Table 3 . Sixty-one patients received platinum-based induction chemotherapy followed by CRT, with most receiving weekly carboplatin. Twenty-seven patients received primary concurrent CRT with weekly carboplatin and paclitaxel or bolus cisplatin. External beam radiation was delivered using a 3-field or conformal technique until approximately 2004, after which point intensity-modulated radiotherapy was most commonly used. The total radiation dose to the primary and grossly involved nodes was 70 to 72 Gray at 1.8 to 2 Gray per day. Information about radiation technique and total dose was not available for 12 of 88 (13.6%) patients.
ND Variables
ND characteristics are listed in Table 4 . NDs were performed at a median of 10 weeks (range, 4-19.7 weeks) after CRT. Eighty-four patients underwent unilateral ND, and 4 patients had simultaneous bilateral NDs. Twenty-eight of 88 (32%) patients experienced at least 1 complication after ND, and 17 of 88 (19%) patients had at least 1 wound complication. Tracheotomy was required in 10 of 88 (11%) patients; 8 of 10 patients required a tracheotomy at the time of ND, and 2 of 10 required a tracheotomy in the postoperative period.
Dysphagia Outcome Measures
Weight loss. Weight changes were reviewed over the follow-up period of 24 months. A peak mean weight loss of 17% was observed at 6 months after CRT. The course of mean weight loss from start of treatment until 24 months after CRT is shown in Figure 1 . Among patients with available weight data, the weight loss was ≥10% of the pretreatment weight in 77% (46/60) at 6 months, in 73% (44/60) at 12 months, and in 58% (35/60) at 24 months.
Diet. The following number of patients were able to take a soft or regular diet at 6, 12, and 24 months: 59 of 88 (67%), 78 of 88 (89%), and 80 of 88 (91%). At both 12 and 24 months, only 1 of 88 (1%) patients was NPO and the remaining 87 of 88 (99%) were able to take an oral diet (Figure 2a) .
GT status. A GT was placed before the start of concurrent CRT in 86 of 88 patients. GT status at different time points is listed in Figure 2b . The median time to GT removal after completion of CRT was 7 months. GT dependence at 6, 12, and 24 months was 47 of 88 (53%), 22 of 88 (25%), and 9 of 88 (10%) patients. Four of the 9 patients with GTs at 24 months subsequently had their GTs removed, between 27 and 41 months after CRT. Only 5 of 88 (6%) patients retained their GTs throughout the entire study period, with a follow-up among these 5 patients ranging from 50 to 129 months. Diet/GT Score. The Diet/GT scores are shown in Figure 2c . At 6, 12, and 24 months, a score of 5 (no GT and soft/regular diet) was achieved in 41 of 88 (47%), 65 of 88 (74%), and 78 of 88 (89%) of patients. During the same time points, a score of 1 (GT present and NPO) was identified in 3 of 88 (3%), 1 of 88 (1%), and 1 of 88 (1%).
Video Swallow Aspiration and Stenosis Results
Significant swallowing difficulties prompted video swallow studies in 58 of 88 (66%) patients, at a median of 11.1 weeks after ND.
On the video swallow study, 43 of 58 (74%) patients were found to have a PAS ≥4. Severe aspiration with insufficient or absent cough reflex, PAS score 7 or 8, was observed in 34 of 58 (58%) patients. Despite high aspiration scores, only 9 of 43 (21%) patients were made NPO at the time of video swallow, and 6 of 9 began an oral diet within 3 months after the video swallow. Five of the 43 (12%) patients developed issues with pneumonia that were effectively medically managed. There were no deaths related to aspiration pneumonia. Ultimately, 39 of 43 (91%) had their GTs removed and tolerated an oral diet.
Pharyngoesophageal stenosis requiring dilation was identified in 26 of 88 (30%) patients on video swallow or endoscopy during ND. In 10 of 26 patients, the stenosis was diagnosed before or at ND, and in 16 of 26 patients, the stenosis was first described after ND. Video swallow studies before ND and esophagoscopies at the time of ND were not always performed; therefore, some of the 16 patients might have also had their stenosis present prior to their ND. All 26 patients underwent dilation; 24 of 26 (92%) patients successfully had their GTs removed, and 21 of 26 (81%) patients returned to a soft or regular diet.
Clinical, Treatment, and ND Factors' Influence on Dysphagia Outcome Measures
Univariate and multivariate analyses were undertaken to determine if clinical, treatment, or ND variables were associated with GT status, Diet/GT score, or stenosis at different time points. The type of radiation therapy could not be considered for statistical analysis because of the small number of patients undergoing the different radiation techniques and because of missing radiation information for 12 of 88 patients. Diet/GT score groups with low patient numbers were combined for optimal statistical analysis. Specifically, patients with scores 1 and 2 were collapsed into one group because both represent GT-dependent patients with very restricted oral intake. Score 3 had achieved adequate patient numbers and was used as a stand-alone group. Score groups 4 and 5, representing GT-independent patients, taking all nutrition by mouth, were collapsed into one group. This created 3 diet/GT groups for statistical analysis. 
GT Status
The univariate results for GT status are shown in Table 5 . T-stage was significantly associated with long-term GT dependence at 12 (P = .003) and 24 (P = .03) months. T-stage remained significant when adjusting for neck stage, time of ND, and type of chemotherapy (P = .01 at 12 months and P = .04 at 24 months). Among ND variables, only timing of ND was significant in the univariate analyses (P = .04) but failed to reach significance in the multivariate setting. Other ND variables, including type of ND and ND complications, showed no significant association with GT dependence. Tracheotomy was borderline significantly associated with GT dependence at 24 months (P = .06) using the Fisher exact test but could not be tested in a logistic model due to the small size of this group.
Diet/GT Score
A higher T-stage (P = .01) was associated with a lower Diet/ GT score in the univariate analyses at 12 months ( Table 6) . T-stage continued to be significantly associated with a lower Diet/GT score at 12 months when adjusted for neck stage, time of ND, and type of chemotherapy (P = .02). Tracheotomy was significantly associated with lower Diet/GT score at 12 months using the Fisher exact test (.05).
Pharyngoesophageal Stenosis
Analyses of multiple clinical and treatment factors was performed for association with pharyngoesophageal stenosis identified before and after ND. In the univariate analyses, only induction chemotherapy was statistically significant, P = .05. Among the 26 patients who developed stenosis, 22 underwent induction chemotherapy and 4 received primary CRT. Induction chemotherapy proved to be associated significantly with stenosis (P = .04) in the multivariate model, which also included T-stage as well as type of chemotherapy.
Discussion
The goals of this study were to characterize dysphagia in patients undergoing ND after CRT and to identify factors contributing to swallowing difficulty. Dysphagia was common during the first 6 Abbreviations: CI, confidence interval; CRT, chemoradiotherapy; MRND, modified radical neck dissection; ND, neck dissection; OR, odds ratio; RND, radical neck dissection.
months after treatment. There was substantial improvement in swallowing ability between 6 and 12 months, and there was slight further improvement between 12 and 24 months after treatment. Ultimately, at 24 months, nearly all patients regained their ability to take an oral diet and had their GTs removed. T-stage was identified as a significant factor contributing to dysphagia in patients undergoing ND after CRT. The need for and benefit gained from post-CRT ND have been called into question, [15] [16] [17] [18] leading to further scrutiny regarding the risks and complications from ND after CRT. 19, 20 In contrast to the well-investigated impact of CRT on swallowing, 4, 8, 9 less is known about the additional contribution of ND to post-CRT dysphagia. Graner et al 6 suggested that further fibrosis after ND may increase pharyngeal dysfunction and consequently potentiate post-CRT dysphagia. An analysis by the Radiation Therapy Oncology Group 12 revealed a significantly higher rate of severe late toxicities, described as feeding tube dependence >2 years and pharyngeal-or laryngeal-related toxicity, among patients undergoing ND after CRT as compared with patients treated with CRT and no ND. These findings were corroborated by Lango et al, 13 who found an increased risk for GT dependence beyond 18 months in patients undergoing post-CRT ND as compared with those not undergoing ND. Graner et al 6 also found worse dysphagia Performance Status Scale scores in patients treated with ND after intra-arterial CRT as compared with those without ND. These reports raise concern that ND may further increase swallowing difficulty in patients receiving CRT for advanced HNC.
Comparison of reports regarding swallowing function after CRT are often confounded by use of different dysphagia measures at varying time points. We used weight loss, diet, GT status, video swallow results, and the newly created Diet/GT score at 6, 12, and 24 months following CRT.
Our diet assessment revealed that 89% and 91% patients were able to take a soft or regular diet at 12 and 24 months. We were unable to identify any other ND post-CRT diet results for direct comparison. Furthermore, even among post-CRT swallowing reports, very few investigators have described the type of diet tolerated at 12 and 24 months after CRT. Lazarus et al 21 reported that 94% of patients were able to eat a soft diet at 12 months posttreatment. Rademaker et al 22 found that 86% of patients tolerated a soft diet and 56% ate all consistencies after CRT. These post-CRT soft-diet assessments compare favorably to our ND post-CRT results. This limited comparison suggests that ND did not further adversely affect diet at 12 months. The Diet/GT score findings highlight this result, with 74% and 89% of patients achieving score 5 at 12 and 24 months, respectively. Results from the Diet/GT score further demonstrate that the greatest rate of swallowing improvement was between 6 and 12 months, but there was still some improvement between 12 and 24 months following CRT.
We identified GT dependency rates of 25% and 10% at 12 and 24 months. Literature review discovered only 1 other report that describes GT dependency separately for patients undergoing ND following CRT. 13 Lango et al 13 similarly found a GT dependence at 12 months of 29% for patients receiving ND and 24% for patients without a ND. Other reports combine CRT and post-CRT ND patients and describe GT dependency rates of 19% to 25% at 12 months 4,5,10 and 10% to 16% at 24 months. 4, 5, 23 Higher rates of GT dependency at 24 months of 22% and 30% have also been reported by Staar et al 24 and Ang et al. 25 Our GT dependency rates at 12 and 24 months were similar to other post-ND reports and no worse than other reports that combined patients undergoing CRT with and without ND.
An important potential contributor to post-CRT dysphagia is pharyngoesophageal stenosis, which occurred in 26 of 88 (30%) of our patients. Nearly all of our patients underwent successful dilation, regained oral intake, and had their GTs removed. This stenosis rate is comparable with current literature findings reporting the incidences from 9% to 37% in studies that included patients with and without post-CRT ND. 4, [26] [27] [28] Overall, our ND following CRT swallowing results compared favorably with reports in the literature for ND as well as non-ND post-CRT patients. Type of oral diet, 4, 21, 22 rates of GT dependence, 4,5,10,23 and incidence of pharyngoesophageal stenosis 4, [26] [27] [28] were similar between our patient population and prior reports. The addition of ND did not appear to adversely influence swallow results.
We also assessed whether specific clinical, treatment, or ND factors were associated with swallow outcome measures. T-stage was associated with a worse Diet/GT score and increased GT dependence. Others have also identified an association between T-stage and adverse swallowing outcomes. 12, 29, 30 Machtay et al 12 showed that T-stage, T1/2 versus T3/4, was a significant variable for severe late toxicities. Nguyen et al 29 found that patients with large tumors, T3/4 versus T1/2, had an increased risk for aspiration. Additional trends identified among our patients included a borderline association between tracheotomy and Diet/GT score as well as induction chemotherapy and stenosis.
Limitations of our study include its retrospective nature and the lack of a direct comparison to a group of patients who did not undergo ND. Video swallow studies were not available for all patients before and after ND, and this limits assessment of the incidence of stenosis and aspiration. In addition, because of the small sample size, our assessment of primary site, radiation technique, and tracheotomy impact on swallow outcome was limited.
Conclusion
We conclude that despite the addition of ND to CRT, nearly all of our patients regained their swallowing ability and were able to take an oral diet and have their GTs removed by 12 to 24 months after CRT. The addition of ND did not appear to substantially diminish swallow ability as compared with reports in the literature. Higher T-stage was associated with a worse swallow outcome.
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